Show simple item record

dc.contributor.authorJablonka-Shariff, Albina
dc.contributor.authorRoser, Janet F.
dc.contributor.authorBousfield, George R.
dc.contributor.authorWolfe, Michael W.
dc.contributor.authorSibley, Lillian E.
dc.contributor.authorColgin, Mark
dc.contributor.authorBoime, Irving
dc.date.accessioned2013-07-19T22:10:48Z
dc.date.available2013-07-19T22:10:48Z
dc.date.issued2007-01-15
dc.identifier.citationAlbina Jablonka-Shariff, Janet F. Roser, George R. Bousfield, Michael W. Wolfe, Lillian E. Sibley, Mark Colgin, Irving Boime, Expression and bioactivity of a single chain recombinant equine luteinizing hormone (reLH), Theriogenology, Volume 67, Issue 2, 15 January 2007, Pages 311-320, ISSN 0093-691X, http://dx.doi.org/10.1016/j.theriogenology.2006.06.013. (http://www.sciencedirect.com/science/article/pii/S0093691X06004195)en_US
dc.identifier.issn0093-691X (Print)
dc.identifier.issn1879-3231 (Electronic)
dc.identifier.urihttp://dx.doi.org/10.1016/j.theriogenology.2006.06.013
dc.identifier.urihttp://hdl.handle.net/10057/5993
dc.descriptionClick on the DOI link to access this article (may not be free)en_US
dc.description.abstractTo study structure–activity relationships and the role of equine gonadotropins in the normal and pathophysiology of equine reproduction, the availability of purified hormones is essential. Previous expression studies in transfected CHO cells showed inefficient assembly of the human and bovine α and β subunits, resulting in low levels of recombinant LH. The ability to express a single chain bearing genetically linked α and β subunits bypasses this rate-limiting assembly step. A chimera was constructed by overlap PCR in which the carboxy terminal end of the eLHβ subunit was genetically fused to the amino end of the α subunit. This gene was transfected into CHO cells and the recombinant product was purified through multiple steps, including a Fractogel resin separation. Serial dilutions of pituitary derived native eLH and the single chain reLH were compared in an eLH radioimmunoassay (RIA); the concentration curves between the single chain recombinant eLH and the native eLH standard were parallel. The biological activity of the analog was determined in vitro and in vivo using homologous equine models. Testicular tissue from five colts was processed for Leydig cell cultures. Increasing doses of reLH were incubated with equine Leydig cells for 24 h in vitro and testosterone production was determined by RIA. Recombinant eLH stimulated a greater than 15-fold increase in testosterone production in a dose-dependent manner. Quarter Horse breeding stallions were treated with either reLH (n = 5) or saline (n = 3) and plasma testosterone concentrations were measured by RIA. Recombinant eLH stimulated a four-fold increase in circulating testosterone concentrations compared to the saline control. Therefore, the single chain recombinant will be effective for a variety of structure–function analyses and for breeding management in the horse.en_US
dc.language.isoen_USen_US
dc.publisherElsevieren_US
dc.relation.ispartofseriesTheriogenology;
dc.relation.ispartofseries;V.67, No.2
dc.subjectRecombinant single chainen_US
dc.subjectEquineen_US
dc.subjectLHen_US
dc.subjectIn vivoen_US
dc.subjectStallionen_US
dc.titleExpression and bioactivity of a single chain recombinant equine luteinizing hormone (reLH)en_US
dc.typeArticleen_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record